Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Creates and develops therapeutic products for cancer, autoimmune disease and other life-threatening and debilitating diseases.Funding
Funding rounds
Cap Table
Current and past shareholders
Investor | Contacts | Round | |
---|---|---|---|
Bay City Capital LLC |
+1 (415) 676-3830 |
N/A |
Investments
Selected investments
Company | Country | Notes | ||
---|---|---|---|---|
Eos Biotechnology Inc Next generation genomics company that uses the complete human genome to identify new drug targets and develop antibodies against those targets to trea |
United States | N/A |